Sharemaestro Newsreel

AVTR: Avantor Inc. Latest Stock Price, Analysis, News and Trading Ideas

This article provides a brief overview of Avantor Inc. (AVTR), including its current stock price, market capitalization, key financial metrics, and upcoming earnings date. It also highlights recent news related to AVTR's expected earnings and includes trending discussions about other stocks.

Teleflex to host Q2 2026 earnings conference call on August 6

Teleflex Incorporated will host a conference call on August 6, 2026, at 8:00 a.m. Eastern Time to discuss its second-quarter 2026 financial results and provide operational updates. Investors and interested parties can access the live audio webcast through the company's website or pre-register for …

Form 8-K WEST PHARMACEUTICAL SERV For: Jul 23

West Pharmaceutical Services, Inc. filed a Form 8-K on July 23, 2026, to announce its second-quarter 2026 financial results. The report includes a press release (Exhibit 99.1) and presentation materials (Exhibit 99.2) related to these results. The company also confirmed its registration with the …

West Pharmaceutical Services (WST) Q2 Earnings and Revenues Top Estimates

West Pharmaceutical Services (WST) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $2.08 per share. This compares to earnings of $1.84 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

West Pharmaceutical Services Q2 Adjusted Earnings, Net Sales Rise; 2026 Outlook Boosted

West Pharmaceutical Services (WST) reported Q2 adjusted earnings Thursday of $2.37 per diluted share PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a …

Walleye Capital LLC Trims Stock Position in Teleflex Incorporated $TFX

Walleye Capital LLC significantly reduced its stake in Teleflex Incorporated by 89.4% in the first quarter, selling over 285,000 shares. Despite this, Teleflex reported better-than-expected earnings and pays a quarterly dividend, though Wall Street analysts generally hold a "Hold" rating on the stock with …

West Pharmaceutical Services Inc. Bottom Line Rises In Q2

(RTTNews) - West Pharmaceutical Services Inc. (WST) revealed a profit for its second quarter that Increases, from last year The company's bottom line totaled $154.0 million, or $2.15 per share. This compares with $131.8 million, or $1.82 per share, last year. Excluding items, West …

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Avantor, Inc. (NYSE:AVTR) concerning corporate wrongdoing. The firm encourages shareholders who purchased Avantor securities before March 5, 2024, and still hold them, to contact them to assist with the investigation. This law firm specializes …

Earnings Flash (WST) West Pharmaceutical Services, Inc. Posts Q2 Adjusted EPS $2.37 per Share, Vs. FactSet Est of $2.08

West Pharmaceutical Services, Inc. (WST) reported strong Q2 adjusted earnings per share of $2.37, significantly exceeding FactSet's estimate of $2.08. This financial update highlights the company's performance relative to analyst expectations.

793,292 Shares in Embecta Corp. $EMBC Purchased by Walleye Capital LLC

Walleye Capital LLC has purchased 793,292 shares of Embecta Corp. (NASDAQ:EMBC) for approximately $7.0 million, establishing a new 1.34% stake in the company. Embecta's stock has faced significant challenges, including trading near its 12-month low, missing recent earnings estimates, and cutting its dividend, alongside …

West Reports Second-Quarter 2026 Results

West Pharmaceutical Services, Inc. announced strong financial results for the second quarter of 2026, with net sales increasing by 13.8% to $872.3 million and adjusted-diluted EPS rising by 28.8% to $2.37. The company raised its full-year 2026 guidance for both net sales and adjusted-diluted …

Bausch + Lomb Corporation (BLCO) Gets a Hold from Wells Fargo

Wells Fargo maintained a Hold rating on Bausch + Lomb Corporation (BLCO) with an $18.00 price target. Goldman Sachs also issued a Hold rating, while RBC Capital maintained a Buy rating. Bausch + Lomb reported Q1 revenue of $1.24 billion and a GAAP net …

BioLife Solutions Inc

Repligen Corp announced its intent to acquire BioLife Solutions in a cash-and-stock deal valued at approximately $1.5 billion. This acquisition is aimed at expanding Repligen's presence in the rapidly growing cell therapy market. The deal positions Repligen to capitalize on the increasing demand for …

UTMD Q1 2024 Earnings: EPS of $1.09 Highlights Performance Amid Limited Financial Disclosure - Margin Compression Risk

West Pharmaceutical Services (NYSE:WST) Hits New 12-Month High After Earnings Beat

WST Stock Jumps on Q2 Earnings & Sales Beat, EPS View Up on HVP Growth

West Pharmaceutical Services, Inc. WST delivered adjusted second-quarter 2026 earnings per share (EPS) of $2.37, which moved up 28.8% year over year. The figure topped the Zacks Consensus Estimate by 13.9%. The adjustments include expenses related to the amortization of acquisition-related intangible assets, among …

Merit Medical Systems (MMSI) Projected to Post Earnings on Thursday

AtriCure (NASDAQ:ATRC) Posts Earnings Results

AtriCure: Q2 Earnings Snapshot

Teleflex (TFX) Expected to Release Quarterly Earnings on Thursday

Teleflex sets August 6 webcast for results and operations update

AptarGroup (ATR) Expected to Release Earnings on Thursday

Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of "Hold" from Brokerages

Teleflex Incorporated (NYSE:TFX) has received a consensus "Hold" rating from eleven brokerages, with an average 12-month price target of $148.00. The medical technology company recently exceeded quarterly earnings expectations, reporting EPS of $1.39 and revenue of $548.3 million, a 32.3% year-over-year increase. Institutional investors …

Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast

Azenta, Inc. (NASDAQ: AZTA) will host a conference call and webcast on August 6, 2026, to discuss its financial results for the third quarter of fiscal year 2026. The company intends to issue a press release detailing these results after the market closes on …

Goodwin Advises Repligen In Acquisition Of BioLife Solutions For Approximately $1.5 Billion

Goodwin Procter LLP advised Repligen Corporation in its definitive agreement to acquire BioLife Solutions, Inc., for approximately $1.5 billion. The transaction, comprising 64% Repligen common stock and 36% cash, has been unanimously approved by both companies' directors and is expected to close in the …

Intuitive Surgical Confronts Rising Risks From Unauthorized da Vinci and Ion Parts and Service

Intuitive Surgical (ISRG) is facing increased competitive and operational risks due to third parties selling unauthorized or remanufactured parts and providing non-approved services for its da Vinci and Ion systems. These alternative offerings are often cheaper and can extend the life of instruments beyond …

West Pharmaceutical: Q2 Earnings Snapshot

West Pharmaceutical Services Inc. (WST) reported second-quarter profit of $154 million, or $2.15 per share, surpassing Wall Street expectations with adjusted earnings of $2.37 per share. The medical device company also exceeded revenue forecasts, posting $872.3 million. The company provided optimistic guidance for the …

AngioDynamics Inc. (ANGO) awards 17,966 RSUs and performance rights

AngioDynamics Inc. (ANGO) has granted its SVP of Quality and Regulatory, Warren Nighan Jr., 17,966 restricted stock units (RSUs) and 17,966 performance rights. The RSUs will vest in four equal annual installments from July 2027 to 2030, while the performance rights are tied to …

Azenta to announce fiscal Q3 2026 earnings on Aug 4

Azenta, Inc. will announce its fiscal third-quarter 2026 financial results after market close on August 4, 2026, for the period ending June 30, 2026. A conference call and live webcast will follow on August 5, 2026, at 8:30 a.m. Eastern Time to discuss these …

Enterprise value to revenue forward of OraSure Technologies, Inc. – NASDAQ:OSUR

The article provides a financial metric, "Enterprise value to revenue forward," for OraSure Technologies, Inc. (NASDAQ: OSUR). It appears to be a stub or a data point from a financial platform like TradingView, indicating no specific value or further details beyond the title of …

OraSure to announce Q2 2026 financial results on August 5

OraSure Technologies, Inc. is scheduled to release its Q2 2026 financial results on August 5, 2026, after the market closes. This will be followed by a quarterly conference call at 5 p.m. ET, which interested investors can access via a webcast on the company’s …

Anteris Technologies Executes 500 Unquoted Options at US$5.71 Strike, Issuing Common Shares

Anteris Technologies Global Corp. (AVR) has converted 500 unquoted options into common stock. The options were exercised on June 18, 2026, at an exercise price of US$5.71 per share, leading to the issuance of shares on July 22, 2026. This activity is a routine …

Anteris Technologies Completes Exercise of 500 Unquoted Options at US$5.71 Strike Price

Anteris Technologies Global Corp. (AVR) has converted 500 unquoted options into common stock at a strike price of US$5.71 per share, with the exercise taking place on June 18, 2026, and issuance on July 22, 2026. This routine capital management activity, not part of …

Baxter International stock trades steadily as spin-off plans follow mixed 2023 results

Baxter International reported mixed 2023 financial results, with significant revenue of $14.9 billion but a net loss of $2.5 billion attributed to restructuring and portfolio changes. The company is actively working on improving operating margins and is preparing for the spin-off of its kidney-care …

Align Technology stock holds near 2026 levels as investors track margins

Align Technology's stock performance remains closely tied to its latest quarterly results, with revenue at $1.01 billion and a strong gross margin of 70.4%. Investors are focused on the company's ability to sustain revenue growth and margin durability in 2026, especially concerning its Invisalign …

Alcon (SWX:ALC) Stock Looks Undervalued On Cash Flow But Fair On Earnings

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Alcon stock sits at an interesting junction, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a large gap to the current …